Keya Medical hosted a sponsored webinar at SCCT 2026 featuring experts in cardiac CT discussing CCTA evolution beyond anatomical stenosis assessment.
Public source
Publisher name
Public post
Beyond stenosis: bringing anatomy, plaque, and physiology together in CCTA How can quantitative plaque analysis and CT-FFR work together to provide a more comprehensive…
Company
Keya Medical
AI for Smarter Healthcare
- Industry
- Medical Device
- Location
- Seattle, US
- Company size
- 11–50 employees
About Keya Medical
Keya Medical is an international medical technology company developing deep learning-based solutions that support disease diagnosis and treatment. Our CCTA portfolio includes two FDA-cleared software medical devices: DEEPVESSEL FFR, which provides noninvasive physiological assessment of the coronary arteries, and DEEPVESSEL Plaque, which quantifies coronary plaque and stenosis. Together, they provide complementary functional and anatomical insights to support the assessment and management of coronary artery disease. DEEPVESSEL FFR is also CE-marked and NMPA-approved.
See moreDiscover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
Cleerly
Cleerly hosted a webinar featuring Dr. Kevin Young discussing real-world cases using Cleerly COMPARE, an AI-generated reporting tool combining CCTA with expert reader review.
Presence & Recognition
Egg Medical
Egg Medical represented Frits Kramer at the CIRSE 2026 session on how EggNest integrates into existing procedural workflows and supports radiation protection for the entire team.
Presence & Recognition
JenaValve Technology, Inc.
JenaValve Technology, Inc. sponsored the STS webinar 'Shaping the Future of Aortic Regurgitation: A Surgical Perspective' on Thursday, September 24, 7:00 PM ET, virtual.
Presence & Recognition
optimed
optimed is hosting live presentations featuring its first five experts for focused talks, real-world insights, and scientific exchange on the CIRSE 2026 platform.
Presence & Recognition
Volta Medical